Brief: RaQualia Pharma gets sodium channel blocker patent allowance in China
23/09/2016 04:01
Sept 23 (Reuters) - RaQualia Pharma Inc 4579.T :
* Says it received an allowance for sodium channel blocker
substance patent in China (Application No.201380022248.1)
Source text in Japanese:http://rrd.me/HWy2
Further company coverage: 4579.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: jun.cao.reuters.com@reuters.net))